MFG
CRL icon

Magnus Financial Group’s Charles River Laboratories CRL Stock Holding History

Magnus Financial Group’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-833
Closed -$208K – 258
2020
Q4 		$208K Buy
+833
New +$198K 0.02% 300
2020
Q3 		– Sell
-1,728
Closed -$301K – 381
2020
Q2 		$301K Buy
1,728
+38
+2% +$6.07K 0.03% 345
2020
Q1 		$213K Hold
1,690
– – 0.03% 433
2019
Q4 		$258K Hold
1,690
– – 0.04% 366
2019
Q3 		$224K Hold
1,690
– – 0.04% 404
2019
Q2 		$240K Buy
1,690
+25
+2% +$3.39K 0.05% 362
2019
Q1 		$242K Buy
+1,665
New +$219K 0.05% 344

Other funds holding CRL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Magnus Financial Group's CRL Position: Q1 2021 in Review

Magnus Financial Group sold out of Charles River Laboratories (CRL) in Q1 2021, closing a stake of 833 shares — an estimated $208K sold.

Magnus Financial Group first reported a position in CRL in Q1 2019 and held it in 7 quarters. The position peaked at $301K in Q2 2020. 561 funds tracked by Wall St. Rank hold CRL as of Q1 2021.

  • Magnus Financial Group reported no remaining Charles River Laboratories position as of Q1 2021 after selling out during the quarter.
  • Magnus Financial Group sold 833 Charles River Laboratories shares in Q1 2021, an estimated $208K.
  • Magnus Financial Group first reported a position in Charles River Laboratories in Q1 2019 and held it in 7 quarters.
  • Magnus Financial Group's Charles River Laboratories position peaked at $301K in Q2 2020.
  • 561 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2021.

Based on Magnus Financial Group's 13F filing for Q1 2021, filed 5 May 2021.